How genomics is becoming a routine tool across research and healthcare
Leandro Neves, Senior Global Director of R&D Genomics at LGC, discusses the technologies, challenges, and opportunities shaping the future of genomic analysis
Leandro Neves, Senior Global Director of R&D Genomics at LGC, discusses the technologies, challenges, and opportunities shaping the future of genomic analysis
How the latest Vero electronic pipettes from Rainin are bringing consistency, comfort, and control to labs
New Orbitrap platforms, AI-enabled software and integrated workflows deliver deeper insight, more confident development decisions and stronger results across complex scientific markets
Crown Bioscience’s in vitro model offers a physiologically relevant tool to evaluate drug efficacy for hematological diseases
The partnership aims to make product protocols accessible for eLabProtocols users
For the chance to win a $500 Amazon Gift Card (or equivalent currency) cast your vote for the new product that has made the most difference to your research
Waters has acquired technology assets and intellectual property rights of Megadalton Solutions, an early-stage developer of charge detection mass spectrometry (CDMS).
The partnership hopes to bolster the effort to provide commerical-grade cell and gene therapy solutions
Bath-based digital science publisher visits nearby life sciences supplier following royal reception at Windsor Castle
As the first laboratory to validate Ki-67 IHC MIB-1 pharmDx Quest plans to make testing available nationally by the end of October 2021
Learn about the pioneering work of the Columbia Stem Cell Initiative and how technological advancements are helping drive scientific breakthroughs at its Flow Cytometry Core Facility
Identification of Impurities in Industrial Quartz Using the LSX-213 Depth Profiling Method
High Mass Resolution is Essential for Confident Compound Detection
The InfinityLab Pro iQ is a next-generation, small-footprint mass detector for LC
Solvent for volumetric titration of Oil based samples
Expected to be first commercially-available blood-based invitro diagnostic for patients being assessed for Alzheimer’s disease in the US
The SHT41 is now available and the SHT45 will be following in Q1/2022